Publications
Download CSV
Download XLSX
Download TXT
Tables
2025 (4)
2024 (528)
2023 (586)
2022 (724)
2021 (1399)
2020 (842)
All (4083)
Labels
Labels list
Labels table
Researchers
Subset
Documentation
About
Contact
Software
Login
Research Area: Vaccine
JSON
CSV
XLSX
TXT
Primary
: Shown in the list of current labels.
Year 2022
PubMed
DOI
Crossref
Effectiveness of COVID-19 Vaccines over 13 Months Covering the Period of the Emergence of the Omicron Variant in the Swedish Population.
Xu Y
, Li H,
Kirui B
, ...,
Vanfleteren LEGW
, Nyberg F
Vaccines
10
(12) - [2022-12-05; online 2022-12-05]
Category: Health
Category: Omicron VoC
Category: Vaccines
Funder: KAW/SciLifeLab National COVID program
Funder: VR
Research Area: Vaccine
Topics: Register-based research
Type: Journal article
PubMed
DOI
Crossref
An intersectional analysis of sociodemographic disparities in Covid-19 vaccination: A nationwide register-based study in Sweden.
Spetz M, Lundberg L, Nwaru C, ..., Nyberg F, Rosvall M
Vaccine
40
(46) 6640-6648 [2022-11-02; online 2022-09-28]
Category: Health
Category: Public Health
Funder: KAW/SciLifeLab National COVID program
Research Area: Vaccine
Topics: Register-based research
Type: Journal article
PubMed
DOI
Crossref
B-cell repopulation dynamics and drug pharmacokinetics impact SARS-CoV-2 vaccine efficacy in anti-CD20-treated multiple sclerosis patients.
Asplund Högelin K
, Ruffin N, Pin E, ..., Piehl F, Al Nimer F
Eur J Neurol
29
(11) 3317-3328 [2022-11-00; online 2022-07-20]
Category: Biochemistry
Category: Health
Category: Vaccines
Funder: KAW/SciLifeLab National COVID program
Funder: VR
Research Area: Vaccine
Type: Journal article
PubMed
DOI
Crossref
A third dose of the unmodified COVID-19 mRNA vaccine CVnCoV enhances quality and quantity of immune responses.
Lenart K, Hellgren F, Ols S, ..., Petsch B, Loré K
Mol Ther Methods Clin Dev
-
(-) - [2022-10-06; online 2022-10-06]
Category: Biochemistry
Category: Health
Category: Vaccines
Funder: KAW/SciLifeLab National COVID program
Research Area: Vaccine
Type: Journal article
PubMed
DOI
Crossref
COVID-19 clinical outcomes and DMT of MS patients and population-based controls.
Longinetti E
, Bower H,
McKay KA
, ..., Piehl F,
Frisell T
Ann Clin Transl Neurol
9
(9) 1449-1458 [2022-09-00; online 2022-08-22]
Category: Biochemistry
Category: Health
Category: Vaccines
Funder: VR
Research Area: Vaccine
Type: Journal article
PubMed
DOI
Crossref
The social patterning of Covid-19 vaccine uptake in older adults: A register-based cross-sectional study in Sweden.
Spetz M, Lundberg L, Nwaru C, ..., Rosvall M, Nyberg F
Lancet Reg Health Eur
15
(-) 100331 [2022-04-00; online 2022-02-26]
Category: Health
Category: Public Health
Research Area: Vaccine
Topics: Register-based research
Type: Journal article
PubMed
DOI
Crossref
Long-term SARS-CoV-2-specific and cross-reactive cellular immune responses correlate with humoral responses, disease severity, and symptomatology.
Laurén I
, Havervall S,
Ng H
, ..., Thålin C,
Mangsbo S
Immun Inflamm Dis
10
(4) e595 [2022-04-00; online 2022-03-30]
Category: Biochemistry
Category: Health
Funder: KAW/SciLifeLab National COVID program
Research Area: High-throughput and high-content serology
Research Area: Vaccine
Type: Journal article
PubMed
DOI
Crossref
NK cell frequencies, function and correlates to vaccine outcome in BNT162b2 mRNA anti-SARS-CoV-2 vaccinated healthy and immunocompromised individuals.
Cuapio A, Boulouis C, Filipovic I, ..., Aleman S,
Ljunggren HG
Mol Med
28
(1) 20 [2022-02-08; online 2022-02-08]
Category: Biochemistry
Category: Health
Funder: KAW/SciLifeLab National COVID program
Funder: VR
Research Area: Vaccine
Type: Journal article
PubMed
DOI
Crossref
T cell immune responses following vaccination with mRNA BNT162b2 against SARS-CoV-2 in patients with chronic lymphocytic leukemia: results from a prospective open-label clinical trial.
Blixt L, Wullimann D, Aleman S, ..., Hansson L, Österborg A
Haematologica
-
(-) - [2022-01-20; online 2022-01-20]
Category: Biochemistry
Category: Health
Category: Vaccines
Funder: KAW/SciLifeLab National COVID program
Funder: VR
Research Area: Vaccine
Type: Journal article
PubMed
DOI
Crossref
Spike-Dependent Opsonization Indicates Both Dose-Dependent Inhibition of Phagocytosis and That Non-Neutralizing Antibodies Can Confer Protection to SARS-CoV-2.
Bahnan W, Wrighton S, Sundwall M, ..., Rasmussen M, Nordenfelt P
Front Immunol
12
(-) 808932 [2022-01-14; online 2022-01-14]
Category: Biochemistry
Category: Health
Category: Vaccines
Funder: KAW/SciLifeLab National COVID program
Research Area: Vaccine
Type: Journal article
PubMed
DOI
Crossref
Salivary IgG to SARS-CoV-2 indicates seroconversion and correlates to serum neutralization in mRNA-vaccinated immunocompromised individuals
Healy K,
Pin E
, Chen P, ...,
Aleman S
, Sällberg Chen M
Med (N Y)
-
(-) - [2022-01-00; online 2022-01-00]
Category: Biochemistry
Category: Health
Category: Vaccines
Funder: KAW/SciLifeLab National COVID program
Funder: VR
Research Area: Vaccine
Type: Journal article
DOI
Crossref
Characterizing Post-COVID Syndrome in Outpatient and Inpatient Setting in Sweden Using Diagnosis Codes - A Nationwide Observational Cohort and Matched Cohort Study
Ollila HM, Fonseca O, Caspersen IH, ..., Eriksson M, Fors Connolly AM
SSRN Journal
-
(-) - [2022-00-00; online 2022-00-00]
Category: Health
Category: Post-COVID
Research Area: Vaccine
Topics: Register-based research
Type: Preprint
Year 2021
PubMed
DOI
Crossref
Mapping the human genetic architecture of COVID-19.
COVID-19 Host Genetics Initiative
Nature
600
(7889) 472-477 [2021-12-00; online 2021-07-08]
Category: Genomics & transcriptomics
Category: Health
Funder: KAW/SciLifeLab National COVID program
Funder: VR
Research Area: Biobanks for COVID-19 research
Research Area: Vaccine
Type: Journal article
PubMed
DOI
Crossref
Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial.
Bergman P, Blennow O, Hansson L, ..., Aleman S, COVAXID-collaborator group (shown separately)
EBioMedicine
74
(-) 103705 [2021-11-29; online 2021-11-29]
Category: Biochemistry
Category: Health
Category: Vaccines
Funder: KAW/SciLifeLab National COVID program
Research Area: Vaccine
Type: Journal article
PubMed
DOI
Crossref
Longitudinal Follow Up of Immune Responses to SARS-CoV-2 in Health Care Workers in Sweden With Several Different Commercial IgG-Assays, Measurement of Neutralizing Antibodies and CD4+ T-Cell Responses.
Marklund E, Leach S, Nyström K, ..., Bemark M, Gisslén M
Front Immunol
12
(-) 750448 [2021-11-02; online 2021-11-02]
Category: Biochemistry
Category: Health
Funder: Hjärt-Lungfonden
Funder: KAW/SciLifeLab National COVID program
Research Area: Biobanks for COVID-19 research
Research Area: Host cell systems biology and targets
Research Area: Vaccine
Type: Journal article
DOI
Crossref
Adverse events of special interest for COVID-19 vaccines - background incidences vary by sex, age and time period and are affected by the pandemic
Nyberg F
, Lindh M, Vanfleteren LEGW, ..., Kirui BK, Gisslén M
MedRxiv
-
(-) - [2021-10-05; online 2021-10-05]
Category: Health
Category: Vaccines
Funder: KAW/SciLifeLab National COVID program
Research Area: Vaccine
Topics: Register-based research
Type: Preprint
PubMed
DOI
Crossref
Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination
Normark J, Vikström L, Gwon YD, ..., Ahlm C,
Forsell M
N Engl J Med
385
(11) 1049-1051 [2021-09-09; online 2021-09-09]
Category: Biochemistry
Category: Drug Discovery
Category: Vaccines
Funder: KAW/SciLifeLab National COVID program
Funder: VR
Research Area: Vaccine
Type: Journal article
PubMed
DOI
Crossref
Development of humoral and cellular immunological memory against SARS-CoV-2 despite B cell depleting treatment in multiple sclerosis
Asplund Högelin K,
Ruffin N
, Pin E, ..., Piehl F, Al Nimer F
iScience
24
(9) 103078 [2021-09-00; online 2021-09-00]
Category: Biochemistry
Category: Health
Funder: KAW/SciLifeLab National COVID program
Research Area: High-throughput and high-content serology
Research Area: Vaccine
Type: Journal article
PubMed
DOI
Crossref
Swedish Covid-19 Investigation for Future Insights - A Population Epidemiology Approach Using Register Linkage (SCIFI-PEARL).
Nyberg F
, Franzén S, Lindh M, ..., Björck S,
Gisslén M
CLEP
13
(-) 649-659 [2021-07-30; online 2021-07-30]
Category: Public Health
Category: Vaccines
Funder: Hjärt-Lungfonden
Funder: KAW/SciLifeLab National COVID program
Funder: VR
Research Area: Vaccine
Type: Journal article
PubMed
DOI
Crossref
Vaccine allergy: evidence to consider for COVID-19 vaccines.
Nilsson L, Csuth Á, Storsaeter J, Garvey LH, Jenmalm MC
Curr Opin Allergy Clin Immunol
-
(-) - [2021-06-04; online 2021-06-04]
Category: Health
Category: Vaccines
Research Area: Vaccine
Type: Journal article
SciLifeLab Data Centre
Publications
9.5.1